Molecule that senses influenza A (flu) identified

August 24, 2009 01:13 pm | Updated December 17, 2016 03:41 am IST - CHENNAI:

Photo: Sampath Kumar

Photo: Sampath Kumar

At a time when influenza A(H1N1) is in the news, researchers have found a reason to cheer: they have identified a cellular molecule that not only senses two common respiratory viruses but also mounts a defense to destroy them. The findings have been published online in the journal Nature Immunology .

The two respiratory viruses are influenza A (flu) and human respiratory syncytial virus (RSV).

The finding is significant as the NOD2, the cellular molecule, can be used to boost the immune system. Any therapies that come up based on the understanding of this molecule can activate the NOD2 gene during and prior to infection.

According to Santanu Bose, senior author from the University of Texas Health Science Center at San Antonio, mice that lacked this crucial molecule survived only for ten days after infection compared with up to eight weeks for mice that had the molecule.

Influenza A (flu) is common during monsoon and winter in India. Though it is self-limiting in most cases, it can be severe and even cause deaths in infants and the elderly and those with certain health conditions such as diabetes, asthma or heart disease.

According to the WHO, every year, about 3-5 million suffer from severe illness, and 2.5 lakh to 5 lakh die of flu. In the U.S. alone, according to the Centers for Disease Control and Prevention (CDC), about 2.5 lakh get hospitalised and about 35,000 die every year from flu.

Much like the case of the flu, healthy people recover from RSV in 1 to 2 weeks' time. But it can be severe in the case of the elderly and young children. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.